TLRY vs TRLV
Tilray Brands, Inc. and Trulieve Cannabis Corp., side by side — 7 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | TLRY | TRLV |
|---|---|---|
| Revenue | $915.5M | $1.2B |
| Net income | $-121.4M | $-122.2M |
| Gross margin | 28.4% | 60.2% |
| Net margin | −11.5% | −10.3% |
| Return on equity | −7.8% | — |
| Diluted EPS | −$1.09 | −$0.58 |
| Dividend / share | — | — |
| Payout ratio | — | — |
| Free cash flow | — | $228.6M |
| Equity | $1.6B | — |
| Net debt / equity | −0.13× | — |
| Current ratio | 2.21× | 4.43× |
| Revenue CAGR 5y | 12.3% | 17.8% |
| Profit CAGR 5y | — | — |
TRLV bills 1.3× the revenue of TLRY, and both closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Revenue by year
7 years side by side
| Fiscal year | TLRY | TRLV |
|---|---|---|
| FY2025 | $915.5M | $1.2B |
| FY2024 | $821.3M | $1.2B |
| FY2023 | $788.9M | $1.1B |
| FY2022 | $627.1M | $1.2B |
| FY2021 | $628.4M | $931.9M |
| FY2020 | $513.1M | $521.5M |
| FY2019 | $405.3M | $252.8M |
Net income by year
Bottom line
| Fiscal year | TLRY | TRLV |
|---|---|---|
| FY2025 | $-121.4M | $-122.2M |
| FY2024 | $-2.2B | $-160.6M |
| FY2023 | $-245.0M | $-533.1M |
| FY2022 | $-1.5B | $-252.7M |
| FY2021 | $-476.8M | $17.4M |
| FY2020 | $-367.4M | $63.0M |
| FY2019 | $-102.5M | $53.1M |
More in this industry